American Health Dispatch
Get the latest news from the Bloomberg American Health Initiative delivered to your inbox, every Friday morning.
Bloomberg Fellow
Samantha is a Clinical Specialist at the University of California, Los Angeles (UCLA) Integrated Substance Abuse Programs (ISAP). Her work at UCLA ISAP, in collaboration with California's Department of Health Care Services (DHCS), focuses on implementing a program to expand access to evidence-based interventions for individuals living with stimulant use disorder, specifically Contingency Management (CM). The goal is to provide CM as a benefit to California residents enrolled in Medicaid, with the potential for the program to serve as a model for implementing Medicaid-covered CM benefits nationwide.
The UCLA Integrated Substance Abuse Programs (ISAP) is located within the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at UCLA and the UCLA Semel Institute for Neuroscience and Human Behavior. ISAP is dedicated to conducting research aimed at developing and evaluating innovative approaches for the treatment of substance use disorders. They integrate empirically supported treatments into mainstream implementation through research dissemination and clinical training programs.
Get the latest news from the Bloomberg American Health Initiative delivered to your inbox, every Friday morning.